搜尋結果

共 2023 個結果
頁數:1...14 15 16 17 18 19 20 21 22 ...102

Don’t bet on a soft landing

In 2021, the big debate about the outlook for the global economy focused on whether the rising inflation in the United States and other advanced economies was transitory or persistent. Key central ban ...More

EJ Insight2022-06-01

How will China’s currency respond to slower growth?

The rise of China into the upper echelons of the world economic order underscores the sway it has over how the global economy performs from the perspective of its appetite for commodities from grains ...More

EJ Insight2022-06-01

脫歐後優勢盡失

這次到西班牙旅遊,是我在脫歐之後第一次到歐洲。對於英國居民來說,入境程序大致一樣,接種了兩劑疫苗或以上的人,只 ...全文

今日信報副刊文化盡付笑談毛羨寧2022年05月31日

Reducing plastic pollution at source

The fifth wave of COVID-19 epidemic in Hong Kong has been severe. In order to curb the spread of the epidemic, the government adopted stricter anti-epidemic measures, including banning dining in resta ...More

EJ Insight2022-05-30

Has the US damaged Africa’s COVID-19 vaccination drive?

The United States Food and Drug Administration’s recent decision to limit the use of the Johnson & Johnson COVID-19 vaccine to adults who cannot or will not get another vaccine will have profound ...More

EJ Insight2022-05-27

The global hunger crisis is here

Global food prices are soaring. The United Nations Food and Agriculture Organization’s Food Price Index – which covers a basket of basic food commodities (cereals, meat, dairy, vegetable oils, and sug ...More

EJ Insight2022-05-24

開市焦點:納期今早挫1.3% 港股考驗20天線 留意車股

隔晚美股三大指數雖然高收,不過今早美股指數期貨向下,納指期貨更挫1.3%,「黑期」基本持平,料港股今早考驗20 ...全文

即時新聞港股直擊2022年05月24日

君實生物(01877) (修改後標題) 公告及通告 - [內幕消息]

君實生物(01877) 內幕消息- VV116對比PAXLOVID早期治療輕中度COVID-19的III期註冊 ...全文

即時新聞港交所通告2022年05月24日

君實生物(01877) 海外監管公告-業務發展最新情況

君實生物(01877) 海外監管公告 - 上海君實生物醫藥科技股份有限公司關於VV116對比PAXLOVID早 ...全文

即時新聞港交所通告2022年05月23日

君實生物(01877) 其他-業務發展最新情況

君實生物(01877) 內幕消息- VV116對比PAXLOVID早期治療輕中度COVID-19的III期註冊 ...全文

即時新聞港交所通告2022年05月23日

A bird in the hand is worth two in the bush

Risk assets have gotten off to a historically poor start in 2022, a year in which seemingly diversified portfolios have been generating undiversified returns. Stocks and government bonds are down by d ...More

EJ Insight2022-05-20

Another global recession?

At the start of the year, I expressed concerns about the outlook for financial markets, owing to all the considerable uncertainties that I could identify, and to the many other potential risks that we ...More

EJ Insight2022-05-19

在社會邊緣的非染疫額外死亡

確診和死亡這兩個疫情統計數字,兩年多以來一直是焦點,也許是社會大眾真切關心,也許是傳媒朋友不離不棄,直至今時今 ...全文

今日信報理財投資經濟3.0曾國平2022年05月19日

Latest HK regulatory developments in the ESG space

The global economic downturn caused by the COVID-19 pandemic and unprecedented spread of wildfires across five continents have reinvigorated scrutiny from investors and consumers of ecological and soc ...More

EJ Insight2022-05-18

Fiscal capture at the ECB

Since the second quarter of 2021, inflation in the United Kingdom, the United States, and the eurozone has far exceeded their central banks’ 2% target. This surge could well be explained by the unexpe ...More

EJ Insight2022-05-17

美國國債激增影響美元資產安全

俄羅斯向烏克蘭採取軍事行動,引發以美國為首的西方國家向俄國實施對靶金融及經貿制裁,促使國際輿論共識到美元霸權地 ...全文

今日信報時事評論黃伯農2022年05月17日

抗疫憤怒

約了五位朋友飯敍,座位早幾天訂好了。到了吃飯當天,收到朋友快測結果照片;原來其中一位朋友,要求所有人見面之前要 ...全文

今日信報副刊文化此時此刻劉健威2022年05月17日

購涵蓋新冠保障旅遊保 外遊更放心

隨着各地對COVID-19(新冠病毒)的防控措施日漸放寬,市民到外地公幹和旅遊的機會增加。然而,現時不少國家都 ...全文

今日信報理財投資通識保險許詩賢2022年05月14日

Breathing new life into medical oxygen

COVID-19 has taken at least 18 million lives, and it is anyone’s guess how many of those deaths were due to a lack of medical oxygen. Governments don’t want to talk about the issue, because that could ...More

EJ Insight2022-05-13

Can the international community still do big things?

When US Secretary of the Treasury Henry Morgenthau opened the Bretton Woods Conference almost 80 years ago, he reminded delegates that failures of international cooperation had led to the Great Depres ...More

EJ Insight2022-05-13

頁數:1...14 15 16 17 18 19 20 21 22 ...102

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。